Skip to content
  • Home
  • Signal News
  • Biopharma Digest
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact

Pharminent

 Posted in Policy / Pricing

Minnesota’s 340B Hospitals Make One Billion More From 340B Than They Spend on Uncompensated Care

 April 23, 2026

Drug Channels

By Bryce Platt, PharmD Minnesota’s new 340B data reveal a growing disconnect between the program’s size and the value Minnesotans receive in return.

Policy / PricingRead full story

Post navigation

Sanofi receives FDA approval for Tzield in paediatric diabetes →
← AAN 2026: J&J, Kyverna, Capricor and Praxis showcase practice-changing data

Categories

© 2026 Pharminent. All rights reserved.

Design by ThemesDNA.com